Citigroup raises Bio-Techne's PT to $80, maintains Buy rating.

Thursday, Feb 5, 2026 3:32 pm ET1min read
C--
TECH--

Citigroup raises Bio-Techne's PT to $80, maintains Buy rating.

Citigroup raises Bio-Techne's PT to $80, maintains Buy rating.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet